Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Net Income (2016 - 2026)

Standard Biotools has reported Net Income over the past 16 years, most recently at $5.4 million for Q4 2025.

  • Quarterly Net Income rose 178.01% to $5.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$39.4 million through Dec 2025, up 38.71% year-over-year, with the annual reading at -$16.1 million for FY2025, 66.48% up from the prior year.
  • Net Income was $5.4 million for Q4 2025 at Standard Biotools, up from -$3.0 million in the prior quarter.
  • Over five years, Net Income peaked at $20.7 million in Q4 2023 and troughed at -$76.3 million in Q1 2022.
  • The 5-year median for Net Income is -$17.1 million (2021), against an average of -$20.1 million.
  • Year-over-year, Net Income crashed 305.33% in 2022 and then surged 185.57% in 2023.
  • A 5-year view of Net Income shows it stood at -$13.9 million in 2021, then crashed by 74.3% to -$24.2 million in 2022, then surged by 185.57% to $20.7 million in 2023, then plummeted by 133.36% to -$6.9 million in 2024, then soared by 178.01% to $5.4 million in 2025.
  • Per Business Quant, the three most recent readings for LAB's Net Income are $5.4 million (Q4 2025), -$3.0 million (Q3 2025), and -$15.8 million (Q2 2025).